All In Biotech

Drug Trial Radar · NCT02913482

Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy

A Two Part Seamless, Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Infants With Type 1 Spinal Muscular Atrophy

Last checked: Nov 19, 2026Latest source record: Aug 7, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

62

Actual

Start

Dec 23, 2016

Primary completion

Nov 14, 2019

Study completion Dec 22, 2023

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Sep 23, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 month, up to 7 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Open-label, multi-center clinical study is to assess the safety, tolerability, pharmacokinetic (PK), pharmacodynamics (PD), and efficacy of Risdiplam (RO7034067) in infants with Type 1 spinal muscular atrophy (SMA). The study consists of two parts, an exploratory dose finding part (Part 1) and a confirmatory part (Part 2) which will investigate Risdiplam (RO7034067) for 24-months at the dose selected in Part 1.

Conditions

  • Muscular Atrophy, Spinal

Interventions

  • RisdiplamDrug

    Risdiplam will be administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part 1: Selected Part 2 Dose of RisdiplamTime frame: Minimum of 2 weeks at steady state exposure
  2. Part 2: Percentage of Infants Who Are Sitting Without Support for at Least 5 Seconds as Assessed by Item 22 of the Gross Motor Scale of the Bayley Scales of Infant and Toddler Development Third Edition (BSID-III) at Month 12Time frame: Month 12

Locations

32 sites in 16 countries. Site status is shown where the registry gives one.

  • Stanford University Medical Center

    Palo Alto, California

  • Ann and Robert H. Lurie Children Hospital of Chicago

    Chicago, Illinois

  • Boston Childrens Hospital

    Boston, Massachusetts

  • Columbia University Medical Center; The Neurological Institute of New York

    New York, New York

  • UZ Gent

    Ghent, Belgium

  • UZ Leuven Gasthuisberg

    Leuven, Belgium

  • Chr de La Citadelle

    Liège, Belgium

  • Instituto de Puericultura E Pediatria Martagão Gesteira

    Rio de Janeiro, Rio de Janeiro, Brazil

  • Hospital das Clinicas - FMUSP_X; Neurologia

    São Paulo, São Paulo, Brazil

  • Peking University First Hospital

    Beijing, China

  • Children's Hospital of Fudan University

    Shanghai, China

  • Clinical Medical Center Zagreb; University Hospital Rebro Department of Paediatrics

    Zagreb, Croatia

  • Hopital Femme Mere Enfant; Medecine Physique et Readaptation Pediatrique ? L?ESCALE

    Bron, France

  • Hopital Armand Trousseau

    Paris, France

  • IRCCS Ospedale Pediatrico Bambino Gesù; U.O. Malattie Neuromuscolari e Neurodegenerative

    Rome, Lazio, Italy

  • Policlinico Agostino Gemelli; Dipartimento di Neuropsichiatria Infantile

    Rome, Lazio, Italy

  • IRCCS Istituto Giannina Gaslini; U.O.S.D. Centro di Miologia e Patologie Neurodegenerative

    Genoa, Liguria, Italy

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Unità Operativa Complessa di Neurologia

    Milan, Lombardy, Italy

  • Fondazione IRCCS Istituto Neurologico ?Carlo Besta?; UO di Neurologia dello Sviluppo

    Milan, Lombardy, Italy

  • Hyogo Medical University Hospital

    Hyōgo, Japan

  • Szpital Gdanskiego Uniwersytetu Medycznego; Clinic of developmental neurology

    Gda?sk, Poland

  • The Children?s Memorial Health Institute Department of Neurology and Epileptology

    Warsaw, Poland

  • Russian Children Neuromuscular Center of Veltischev

    Moscow, Moscow Oblast, Russia

  • King Faisal Specialist Hospital and Research Centre Building

    Riyadh, Saudi Arabia

  • Institute for Mother and Child Dr. Vukan Cupic

    Belgrade, Serbia

  • Hospital Universitari Vall d'Hebron; Area Genética Clínica y Molecular

    Barcelona, Spain

  • Hospital Universitario Virgen del Rocio

    Seville, Spain

  • Hospital Sant Joan De Deu

    Esplugues de Llobregas, Barcelona, Spain

  • Universitäts-Kinderspital (UKBB) Neuropädiatrie

    Basel, Switzerland

  • Hacettepe University, School of Medicine; Pediatrics Department; Pediatrics Child Neurology Unit

    Ankara, Turkey (Türkiye)

  • Hospital Yeditepe University Kozyatagi; Pediatry

    Atasehir- Istanbul, Turkey (Türkiye)

  • Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology

    Kharkiv, Ukraine

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.